Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Inventory Average (2017 - 2025)

Ptc Therapeutics has reported Inventory Average over the past 9 years, most recently at $66.2 million for Q4 2025.

  • Quarterly results put Inventory Average at $66.2 million for Q4 2025, up 124.81% from a year ago — trailing twelve months through Dec 2025 was $66.2 million (up 124.81% YoY), and the annual figure for FY2025 was $51.4 million, up 91.26%.
  • Inventory Average for Q4 2025 was $66.2 million at Ptc Therapeutics, up from $43.4 million in the prior quarter.
  • Over the last five years, Inventory Average for PTCT hit a ceiling of $66.2 million in Q4 2025 and a floor of $14.9 million in Q3 2022.
  • Median Inventory Average over the past 5 years was $26.0 million (2023), compared with a mean of $26.7 million.
  • Biggest five-year swings in Inventory Average: surged 127.29% in 2023 and later fell 26.0% in 2025.
  • Ptc Therapeutics' Inventory Average stood at $15.7 million in 2021, then rose by 16.37% to $18.3 million in 2022, then soared by 81.13% to $33.2 million in 2023, then decreased by 11.25% to $29.4 million in 2024, then soared by 124.81% to $66.2 million in 2025.
  • The last three reported values for Inventory Average were $66.2 million (Q4 2025), $43.4 million (Q3 2025), and $27.9 million (Q2 2025) per Business Quant data.